Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Conditions: Dermatomyositis; PolymyositisInterventions: Drug: tocilizumab; Drug: placeboSponsors: University of Pittsburgh; Genentech, Inc.Recruiting - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials